JAN 30, 2016 11:05 PM PST

Therapy seeks and destroys prostate cancer in mice

A new therapy uses white blood cells to ferry cancer-killing proteins through the bloodstream. Tests show it virtually eliminates metastatic prostate cancer in mice.

“The therapy is remarkably effective in vivo and shows several advantages, such as no toxicity and getting good results in very low dosages,” says senior author Michael King, professor of biomedical engineering at Cornell University. “It was our wildest dream to completely prevent the spread of prostate cancer. And that’s what happened in this system.”
 
A single dose of the experimental therapy-even delivered very late in the course of the disease-dramatically reduced the number of tumor cells. "This suggests that it may never be too late to help," says Michael King.

Metastasis is the spread of cancer cells from one tumor to other organs of the body, such as the lungs, the liver, the spleen, and the kidneys. While surgery and radiation treat primary tumors, it remains difficult to detect and reach metastatic cancer cells—which makes the treatment of spreading cancer more treacherous and problematic, King says.

Researchers created nano-sized liposomes with a protein that attaches to leukocytes (white blood cells). The liposomes are about one-one hundredth the size of the white blood cells. As the white blood cells travel throughout the bloodstream, the hitchhiking protein kills the tumor cells—leaving the bloodstream free of cancer.

As reported in the study, published in the Journal of Controlled Release, prostate cancer cells were implanted into the prostate of male mice to let the tumors grow. The treatment prevented secondary tumors, and the primary tumor shrunk in size.

While treated mice showed no metastases, the circulating tumor cell count remained greatly reduced but not completely zero, which leads scientists to believe “you don’t have to be perfect in completely eliminating circulating tumor cells to observe a very good outcome,” King says.

Further, the researchers discovered that a single dose of the therapy—even delivered very late in the course of the disease—can substantially reduce the number of tumor cells. “This suggests that it may never be too late to help,” King says.

The National Cancer Institute funded the research.

This article was originally published on futurity.org.
About the Author
  • Futurity features the latest discoveries by scientists at top research universities in the US, UK, Canada, Europe, Asia, and Australia. The nonprofit site, which launched in 2009, is supported solely by its university partners (listed below) in an effort to share research news directly with the public.
You May Also Like
NOV 29, 2019
Cancer
NOV 29, 2019
How flavonoids fight against colorectal cancer
New research published in the journal Cancers reports why flavonoids can aid in reducing the risk of colorectal cancer. Flavonoids are compounds found in f...
DEC 06, 2019
Health & Medicine
DEC 06, 2019
Study finds association between hair products and breast cancer risk
For many women, hair color and style are significant components of their identity. However, troubling information from a new study about the use of hair dy...
FEB 05, 2020
Genetics & Genomics
FEB 05, 2020
'Chromosome Shattering' is Common Across Cancer Types
A type of genetic mutation called chromothripsis was discovered a few years ago in chronic lymphocytic leukemia....
FEB 04, 2020
Cancer
FEB 04, 2020
The role of SRR in colorectal cancer
Researchers from Osaka University have recently discovered a new function of the multifunctional enzyme entitled serine racemase (SRR). According to the te...
FEB 14, 2020
Cancer
FEB 14, 2020
Cataloging Cancer: DNA fingerprints at work
New research published as part of a global Pan-Cancer Project highlights the world’s most comprehensive catalog to date of DNA fingerprints of cancer...
FEB 13, 2020
Cancer
FEB 13, 2020
Can Ebola help treat glioblastomas?
You might want to sit down for this. New research published in the Journal of Virology has named a surprising new ally to brain tumors: Ebola. Yes, yo...
Loading Comments...